(2'S,4aR,4bS,6aS,7aS,8aS,8bS,8cR)-4a,6a-dimethyl-4,4a,4b,5,6,6a,8,8a,8b,8c-decahydro-2H,3'H-spiro[cyclopropa[4,5]cyclopenta[1,2-a]phenanthrene-7,2'-furan]-2,5'(3H,4'H,7aH)-dione;(15?,16?,17?)-15,16-Dihydro-17-hydroxy-3-oxo-3'H-cyclopropa[15,16]pregna-4,6,15-triene-21-carboxylic Acid ?-Lactone; 17?-Hydroxy-15?,16?-methylene-3-oxo-17?-pregna-4,6-diene-21-carboxylic Acid ?-Lactone; Drospirenone EP Impurity D;6,7-Demethylene-6,7-dehydro Drospirenone; 3-oxo-15α,16α-dihydro-3′H-cyclopropa[15,16]-17α-pregna-4,6-diene-21,17-carbolactone (Δ6-drospirenone),
Drospirenone EP Impurity D is a fully characterized chemical compound used as a reference standard of API Drospirenone. The standard offered is compliant with regulatory guidelines. Drospirenone EP Impurity D is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 67372-69-4
Related products
6ß,7ß,15ß,16ß-Dimethylene-3ß,5ß-dihydroxyandostan-17-one
M.F.
M.W. 330.47
CAT# AR-D02487
CAS# 82543-16-6
3β,5β-Dihydroxy-15β,16β-methylene-androst-6-en-17-one
M.F.
M.W. 316.44
CAT# AR-D02491
CAS# 82543-15-5
